Protect your best assets — trade fairs in Germany: opportunity and threat
An international trade fair is a key opportunity to reach a global audience and to showcase new products and services. But it also presents a significant opportunity for those who choose to ride on the back of your investments and infringe your rights to launch competing products and target the same audience.
As such, a trade fair is often a hotbed of infringement of patents, trademarks and design rights. As one of the world’s export champions and centres for trade fairs across many industries, it is no coincidence that Germany is well set up to deal quickly and effectively with infringements that do occur at trade fairs — provided that you are ready and able to act quickly to enforce your rights.
What steps can you take both before and during the trade fair to ensure that the threat of infringement of your intellectual property rights is minimised?…
Click on the link below to read the rest of the Wragge & Co briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Wragge Lawrence Graham & Co
News from The Lawyer
Briefings from Wragge Lawrence Graham & Co
The most likely option is the use of EC-approved Model Contracts
Court finds EC’s decisions to grant marketing authorisations for two generic products were consistent with legal provision.